Guest: Kris V. Kowdley, MD, AGAF, FAASLD, FACP, FACG Primary biliary cholangitis (PBC) is a chronic cholestatic autoimmune liver disease characterized by a destructive, small duct, and lymphocytic cholangitis, and marked by the presence of antim

Host: Joyce O'Shaughnessy, MD Hormone receptor-positive, HER2-negative cancer is the most common subtype of breast cancer. Initial treatment consists of surgery with or without radiotherapy or chemoradiotherapy, followed by adjuvant endocri

Guest: Surya Bhatt, MD Host: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolog

Host: Carolyn S. P. Lam, MBBS, PhD, MRCP, MS, FACC, FAMS, FESC Guest: Scott Solomon, MD Guest: Mikhail Kosiborod, MD There are limited therapeutic options for patients with heart failure with mid-range or preserved ejection fraction (HFm

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolo

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolo

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolo

Host: Stefan H. Jacobson, MD, PhD Guest: Carlos Narvez Meja, MD Chronic kidney disease-associated pruritus (CKD-aP) is an underreported and underdiagnosed condition that affects a significant proportion of patients with advanced kidney dis

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolo

Guest: Surya Bhatt, MD Guest: MeiLan Han, MD, MS Although chronic obstructive pulmonary disease (COPD) is the fourth leading cause of death worldwide, current management does not alter progression of the disease. With the potential for biolo